FEED

Company Overview — What Does NanoVibronix, Inc. Do?

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. ... NanoVibronix' catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified. NanoVibronix, Inc. (FEED) is classified as a micro-cap stock in the Healthcare sector, specifically within the Medical Equipment industry. The company is led by CEO Brian M. Murphy and employs approximately 20 people. With a market capitalization of $2M, FEED is one of the notable companies in the Healthcare sector.

NanoVibronix, Inc. (FEED) Stock Rating — Avoid (April 2026)

As of April 2026, NanoVibronix, Inc. receives a Avoid rating with a composite score of 18.9/100 and 1 out of 5 stars from the Blank Capital Research quantitative model.FEED ranks #4,344 out of 4,446 stocks in our coverage universe. Within the Healthcare sector, NanoVibronix, Inc. ranks #796 of 838 stocks, placing it in the lower half of its Healthcare peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

FEED Stock Price and 52-Week Range

NanoVibronix, Inc. (FEED) currently trades at $1.68. The stock lost $0.07 (4.0%) in the most recent trading session. The 52-week high for FEED is $17.40, which means the stock is currently trading -90.3% from its annual peak. The 52-week low is $0.67, putting the stock 151.9% above its annual trough. Recent trading volume was 155K shares, suggesting relatively thin trading activity.

Is FEED Overvalued or Undervalued? — Valuation Analysis

NanoVibronix, Inc. (FEED) carries a value factor score of 36/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 0.05x, versus the sector average of 2.75x. The price-to-sales ratio is 0.76x, compared to 1.66x for the average Healthcare stock.

At current multiples, NanoVibronix, Inc. trades at a premium to most Healthcare peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

NanoVibronix, Inc. Profitability — ROE, Margins, and Quality Score

NanoVibronix, Inc. (FEED) earns a quality factor score of 10/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -16.4%, compared to the Healthcare sector average of -43.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -12.8% versus the sector average of -33.1%.

On a margin basis, NanoVibronix, Inc. reports gross margins of 22.6%, compared to 71.5% for the sector. The operating margin is -388.7% (sector: -66.1%). Net profit margin stands at -310.5%, versus -58.7% for the average Healthcare stock. Revenue growth is running at -11.6% on a trailing basis, compared to 10.6% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

FEED Debt, Balance Sheet, and Financial Health

NanoVibronix, Inc. has a debt-to-equity ratio of 2.0%, compared to the Healthcare sector average of 32.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. Total debt on the balance sheet is $1M. Cash and equivalents stand at $7M.

FEED has a beta of 2.24, meaning it is more volatile than the broader market — a $10,000 investment in FEED would be expected to move 123.6% more than the S&P 500 on any given day. The stability factor score for NanoVibronix, Inc. is 5/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

NanoVibronix, Inc. Revenue and Earnings History — Quarterly Trend

In TTM 2026, NanoVibronix, Inc. reported revenue of $3M and earnings per share (EPS) of $-0.91. Net income for the quarter was $-7M. Gross margin was 22.6%. Operating income came in at $-9M.

In Q3 2025, NanoVibronix, Inc. reported revenue of $722,000 and earnings per share (EPS) of $-0.91. Net income for the quarter was $510,000. Gross margin was 26.2%. Revenue grew 92.0% year-over-year compared to Q3 2024. Operating income came in at $-2M.

In Q2 2025, NanoVibronix, Inc. reported revenue of $494,000 and earnings per share (EPS) of $-1.03. Net income for the quarter was $-4M. Gross margin was -7.1%. Revenue grew -39.5% year-over-year compared to Q2 2024. Operating income came in at $-4M.

In Q1 2025, NanoVibronix, Inc. reported revenue of $1M and earnings per share (EPS) of $0.00. Net income for the quarter was $-2M. Gross margin was 36.0%. Revenue grew 11.3% year-over-year compared to Q1 2024. Operating income came in at $-2M.

Over the past 8 quarters, NanoVibronix, Inc. has demonstrated a growth trajectory, with revenue expanding from $921,000 to $3M. Investors analyzing FEED stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

FEED Dividend Yield and Income Analysis

NanoVibronix, Inc. (FEED) does not currently pay a dividend. This is common among smaller companies in the Medical Equipment industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Healthcare dividend stocks may want to explore other Healthcare stocks or use the stock screener to filter by dividend yield.

FEED Momentum and Technical Analysis Profile

NanoVibronix, Inc. (FEED) has a momentum factor score of 13/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 30/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 38/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.

FEED vs Competitors — Healthcare Sector Ranking and Peer Comparison

Within the Healthcare sector, NanoVibronix, Inc. (FEED) ranks #796 out of 838 stocks based on the Blank Capital composite score. This places FEED in the lower half of all Healthcare stocks in our coverage universe. Key competitors and sector peers include ASTRAZENECA PLC (AZN) with a score of 61.4/100, Sol-Gel Technologies Ltd. (SLGL) with a score of 56.6/100, VIEMED HEALTHCARE, INC. (VMD) with a score of 53.4/100, Innoviva, Inc. (INVA) with a score of 52.7/100, and JOHNSON & JOHNSON (JNJ) with a score of 51.7/100.

Comparing FEED against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full FEED vs S&P 500 (SPY) comparison to assess how NanoVibronix, Inc. stacks up against the broader market across all factor dimensions.

FEED Next Earnings Date

No upcoming earnings date has been announced for NanoVibronix, Inc. (FEED) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy FEED? — Investment Thesis Summary

The quantitative profile for NanoVibronix, Inc. suggests caution. The quality score of 10/100 flags below-average profitability. The value score of 36/100 indicates premium valuation. Momentum is weak at 13/100, a headwind for near-term performance. High volatility (stability score 5/100) increases portfolio risk.

In summary, NanoVibronix, Inc. (FEED) earns a Avoid rating with a composite score of 18.9/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on FEED stock.

Related Resources for FEED Investors

Explore more research and tools: FEED vs S&P 500 comparison, top Healthcare stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare FEED head-to-head with peers: FEED vs AZN, FEED vs SLGL, FEED vs VMD.